The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing. Continuous processing for the production of key building blocks and intermediates for ...
API-in-capsule approaches enable pharmaceutical companies to quickly assess new drug candidates with reduced API consumption and to increase speed to clinic. Pharmaceutical companies are faced with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback